key: cord-0878855-33dohaxr
authors: Goud, K. Yugender; Reddy, K. Koteshwara; Khorshed, Ahmed; Kumar, V. Sunil; Mishra, Rupesh K.; Oraby, Mohamed; Ibrahim, Alyaa Hatem; Kim, Hern; Gobi, K. Vengatajalabathy
title: Electrochemical diagnostics of infectious viral diseases: Trends and challenges
date: 2021-05-15
journal: Biosens Bioelectron
DOI: 10.1016/j.bios.2021.113112
sha: 6b8cd33d988337512f72a22bacd2979585fdc3d1
doc_id: 878855
cord_uid: 33dohaxr

Infectious diseases caused by viruses can elevate up to undesired pandemic conditions affecting the global population and normal life function. These in turn impact the established world economy, create jobless situations, physical, mental, emotional stress, and challenge the human survival. Therefore, timely detection, treatment, isolation and prevention of spreading the pandemic infectious diseases not beyond the originated town is critical to avoid global impairment of life (e.g., Corona virus disease - 2019, COVID-19). The objective of this review article is to emphasize the recent advancements in the electrochemical diagnostics of twelve life-threatening viruses namely - COVID-19, Middle east respiratory syndrome (MERS), Severe acute respiratory syndrome (SARS), Influenza, Hepatitis, Human immunodeficiency virus (HIV), Human papilloma virus (HPV), Zika virus, Herpes simplex virus, Chikungunya, Dengue, and Rotavirus. This review describes the design, principle, underlying rationale, receptor, and mechanistic aspects of sensor systems reported for such viruses. Electrochemical sensor systems which comprised either antibody or aptamers or direct/mediated electron transfer in the recognition matrix were explicitly segregated into separate sub-sections for critical comparison. This review emphasizes the current challenges involved in translating laboratory research to real-world device applications, future prospects and commercialization aspects of electrochemical diagnostic devices for virus detection. The background and overall progress provided in this review are expected to be insightful to the researchers in sensor field and facilitate the design and fabrication of electrochemical sensors for life-threatening viruses with broader applicability to any desired pathogens.

Chikungunya, Chickenpox, Dengue, Ebola, Flu, Hepatitis, Influenza, Middle east respiratory 3 syndrome (MERS), Severe acute respiratory syndrome (SARS), and many more (Shah and 4 Wilkins, 2003). A transferable viral particle typically comprises nucleic acids in the core and the enzymatic by-product 1-naphthol was sensed on the carbon-based screen-printed 10 electrode. The analytical performance of the developed biosensor was estimated using a 11 standard solution of viral proteins (S and N) in buffer medium and extended to detect the 12 same in saliva samples ( Figure 2C ). The obtained detection levels in saliva were 19 and 8 ng 13 mL -1 for S and N proteins respectively. 14 On the other hand, Smartphone based ultrasensitive electrochemical sensor was 15 demonstrated for the detection of COVID-19 in patients (Zhao et al., 2021) . The recognition 16 matrix comprised of calixarene functionalized graphene oxide surface was used to detect 17 RNA of COVID-19 by relying on a sandwich-type detection. The method is free from the 18 amplification of nucleic acid and exhibited high specificity during actual testing of COVID 19 patients. The detection limit of the tested samples was found to be 200 copies mL -1 , the 20 lowest till date claimed by authors by offering a simple, low-cost and useful method. Tentative position for Table 1   Table 1 illustrates the summary of different analytical/electrochemical biosensing 9 diagnostics methods for the detection SARS-CoV-2 virus. The limit of detections was 0. fragments were immobilized onto the AuNPs|ITO electrode by self-assembled monolayer 10 method with Au-thiol interaction, followed by the HIV-1 virus-like particle were applied for 11 the direct electron determination. HIV-1 virus particles were detected using CV as 12 transduction technique and observed the response in the concentration range of 600 fg mL -1 -13 375 pg mL -1 (Lee et al., 2013) . 14 Richard G. Compton group reported an electrochemical rapid sensor for the detection 15 of single influenza virus tagged with the silver nanoparticles (AgNPs). Influenza virus 16 concentration was detected while exposing the virus and AgNPs on the carbon nanofiber 17 working electrode. The AgNPs naturally restrict to adsorb on the carbon nanofibers surface, 18 but virus interacted AgNPs were easily adsorbed on the working electrode surface. These 19 changes were recorded by running in-vitro stripping voltammetry technique. In the next stage, 20 single virus detection was achieved via nano-impact technique. Here, random individual 21 nanometer-sized virus collisions with the AgNPs were monitored by using the spikes of 22 chronoamperogram during oxidation or reduction of AgNPs (Sepunaru et al., 2016) . 23 J o u r n a l P r e -p r o o f An electrochemical biosensor was developed for the detection of glycoprotein GP120, 1 a surface protein of HIV1 by using Au/MoS 2 /Au sputtered monolayers on poly ethylene 2 terephthalate (PET) substrate. Here, Au was initially sputtered on the PET substrate and 3 followed by the MoS 2 NPs and Au were spin-coated on the PET/Au surface. Then 4 glycoprotein GP120 antibody was immobilized on Au/MoS 2 /Au surface using cysteamine 5 intermediate layer ( Figure 3A) . The GP120 glycoprotein and antibody interactions were 6 measured by SWV analysis using the Ferry-Ferro redox couple electroactive solution and 7 observed the limit of detection 0.1 pg mL -1 (Shin et al., 2019). well as electrode surface area increased with the aid of AuNPs, which eventually leads to the 20 high sensitivity of the fabricated immunosensor. Biological fluids samples were examined by 21 spiking into the artificial nasal samples and achieved a good recovery limit. Low detection 22

limit was observed as 0.4 pg mL −1 for human corona virus (HCoV) and 1.0 pg mL −1 for 23 A voltammetric immunosensor was developed for the detection of Rotavirus using 1 graphene. The immunosensor was fabricated through sequential steps, primarily with the 2 formation of graphene film by thermal annealing followed by the surface modification with 3 pyrene derivative ( Figure 4B ) (F. Liu et al., 2011). The fabricated immunosensor was used 4 for the formation of Antibody-Antigen complex by covalent linkage, then the responses were 5 recorded with CV. It was able to detect 10 5 PFU mL -1 of input cells with 30.7% sensitivity. 6

On the other hand, electrochemical impedimetric sensor was reported for the detection of 7 rotavirus using gold sono-nanoparticles (AuSNPs). Glassy carbon electrode (GCE) was 8 modified initially with AuSNPs followed by the self-assembled monolayers of cysteamine, 

Ultrasensitive label-free, low-cost electrochemical immunosensor for the detection of 13 hepatitis B virus was demonstrated using modified SPCE (Akkapinyo et al., 2020). Bovine 14 serum albumin was immobilized followed by activation with N-ethyl-N′- (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (dimethylamino)propyl)carbo-diimide/N-hydroxy succinimide (EDC/NHS) chemistry and 16 hepatitis B surface antibodies ( Figure 5A ). Impedimetric response was used to detect HBsAg 17 in a linear range of 5 -3000 ng mL -1 , with a low detection limit of 2.1 ng mL -1 . 18

Development of label free, low-cost impedimetric immunosensor for the detection 19 bovine herpesvirus type 1 antigen (BHV-1 AG) was demonstrated using a simple strategy 20 (Garcia et al., 2020). The immunosensor was constructed with initial activation of the 1 electrode by chronoamperometry followed by the immobilization of appropriate antibody 2 (BHV-1 AB) which was obtained from egg yolk of immunized chickens, then blocking the 3 bare part of electrode surface with casein ( Figure 5B ). Then impedimetric method was 4 applied for the detection of antigen in the range of 10 -50 Median Tissue Culture Infectious 5 Dose (TCID 50 ) TCID 50 mL -1 , with limit of quantification of 2.00 TCID 50 mL -1 and detection 6 limit 0.66 TCID 50 mL -1 . Bioelectronic sensor was demonstrated for the detection of single-molecule, HIV-1 17 p24 capsid protein (Macchia et al., 2020). The sensor system was a low-cost, label-free and 18 highly sensitive platform for the detection of capsid protein HIV-1 p24. It was proposed that a 1 single-molecule transistor (SiMoT) works based on the electrolyte-gated field-effect 2 transistor phenomenon ( Figure 5C ). Gate was bio-functionalized with antibodies and 3 observed the low detection limit of with 30 × 10 −21 M. 4

Electrochemical biosensor was reported for the detection of human norovirus using 5 novel peptides (Baek et al., 2019). Eight peptides were tested as recognition elements, which 6 initially verified individually their effectiveness in sensing the virus and identified that 7

NoroBP peptide coated onto the gold electrode exhibited enhanced binding efficiency and 8 observed the low detection limit 1.7 copies mL -1 ( Figure 5D ). The developed sensor was 9 successfully applied the for the detection of norovirus in oyster. Tentative position for Table 3   Table 3 illustrates the summary of different electrochemical diagnostics methods 7 based on antibody-based recognition elements for the detection of viral infectious diseases. 8

All the relevant articles were arranged in the table with the transduction technique, 9 recognition element/assay, working calibration range and sensor limit of detection. with antibody, these have constantly been employed in various sensors to make it robust and 23 temperature tolerant (Zhou et al., 2014) . Another advantage of the aptamer-based biosensors 1 is their relatively smaller size, which enables them to get access to the deep-seated target sites. 2 Whereas, conventional antibody-based biosensing cannot be able to perform it due to their 3 larger size (Banerjee and Nilsen-Hamilton, 2019), making aptamer an appealing choice to 4 develop the biosensors for various targets including viruses. The virus contains capsid 5 proteins, the genetic materials (either RNA or DNA), and in some viruses a lipid bilayer or 6 envelope for their protection. The electrochemical detection of viruses was achieved by 7 targeting these moieties, mainly using labeled and label-free techniques. In labeled formats 8 the recognition is monitored by the target and aptamer physicochemical interactions with a 9 specific tag, whereas in the label-free formats the detection depends on direct signal The detection of viral proteins has been reported relatively quickly and due to this 2 reason, in the recent COVID-19 pandemic outbreak the biosensors targeting capsid-proteins 3 have been used for preliminary screening of the patients suffering from the disease. Similarly, 4

for the viruses, the aptamer-based detection has also been reported in the recent past, which 5

consists of the selective, robust, specific aptamer probe that has an affinity of binding towards 6 the proteinaceous part of viral-materials (van den Kieboom et al., 2015) . For instance, 7

Ghanbari et al. used the graphene quantum dots based electrochemical sensor probe for 8 detecting core antigen from the HCV. Resistance changes were monitored when the affinity 9 binding exists between the aptamer probe and HCV core antigen. In this report, the developed 10 sensor was capable of detecting the target antigen in a wide concentration range (0-70 pg mL -11 1 and 70 -400 pg mL -1 ) with the detection limit of 3.3 pg mL -1 . The sensor probe was 12 reported to be extremely selective towards the target analyte and also it worked excellently In another report, an ultrasensitive DNA biosensor was developed for the detection of 19 HPV by using EIS and DPV techniques. Initially, the capture probe was immobilized on 20 graphene/Au nanorod/polythionine modified GCE. Two types of auxiliary probes of long size 21 self-assembled DNA structure were immobilized after target DNA. Finally, [Ru(phen) 3 ] 2+ 22 was used as electroactive indicative medium, which was deposited on auxiliary probes due to 23 electrostatic interaction, these changes were recorded by DPV. Based on this principle, The with a minimum sensitivity of 2.6 nV/Zika and the minimum detectable signal of 1.2x10 6 10 Zika. The combination of microfluidics with paper based electrochemical biosensing systems 11 accelerates the development of POC devices for the rapid and onsite detection of viruses. 12 13 Tentative position for Table 4   Table 4 Imprinted polymers, CRISPR based systems, etc.) deliver the best selectivity. Hence, the 5 synergistic combination of both these materials may yield the advanced hybrid 6 nanocomposites thereby facilitates the construction of an ideal biosensor system. 7

In spite of the achieved development in biosensors for the specific detection of viruses 8

using different bio-recognition elements, a plenty of research is yet to be done in the special 9 areas such as utilization of different anti-fouling coating layers to reduce the fouling and 10 adoption of advanced bio-compatible nanomaterials to enhance the sensitivity of the 11 transducer system. Accurate detection of the other biomarker components such as C-reactive 12 protein, interleukins, glutamate, breath pH, TNF-α, interferons, hematological biomarkers 13 apart from the virus particle detection helps to understand the severity of the infection. This 14 dual detection could be achieved using multiplexed electrochemical sensing models with the 15 aid of microfluidic sensing systems, and in turn provide valuable help in the better 16 management of viral pandemic diseases. 17 We believe that the manuscript gives critical insights on the latest developments and 18 could help the researchers in designing an integrated electrochemical multi-sensing system 19 for early, rapid, accurate detection of viral infectious diseases. Qian, X., Tan, S., Li, Z., Qu, Q., Li, L., Yang, L., 2020. A robust host-guest interaction 24 controlled probe immobilization strategy for the ultrasensitive detection of HBV DNA 25 using hollow HP5-Au/CoS nanobox as biosensing platform. Biosens 

Nanomaterial-based biosensors 1 for detection of pathogenic virus

Altered Virome and Bacterial Microbiome in

The impact of biosensing in a pandemic outbreak: 10 COVID-19

Advanced nanotechnologies in avian influenza: Current 14 status and future trends -A review

Pathogenesis and Transmission of Swine-19 Origin 2009 A(H1N1) Influenza Virus in Ferrets

Middle East respiratory syndrome coronavirus neutralising serum 3 antibodies in dromedary camels: a comparative serological study

Label-free aptasensors 6 for the detection of mycotoxins

Development of chip-compatible sample preparation for diagnosis 9 of infectious diseases

HIV biosensors -The potential of the electrochemical way

The Molecular Biology of SARS Coronavirus

Silver 17 nanoparticles impregnated chitosan layered carbon nanotube as sensor interface for 18 electrochemical detection of clopidogrel in-vitro

Rapid 22 Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal 23

Swab Specimens Using Field-Effect Transistor-Based Biosensor

Rapid 26 electrochemical detection of single influenza viruses tagged with silver nanoparticles

Interpreting Diagnostic Tests for SARS-CoV-29 2

Electrochemical Biosensors for Detection of Biological Warfare

Sequences Related to the Human Papillomavirus Type 16 using Methylene Blue

COVID-19 pandemic: perspectives on an unfolding crisis

Pop-up paper electrochemical device for label-free hepatitis B virus DNA 9 detection

Amplification-free DNA Sensor for the One

Virus Using an Automated Paper-Based Lateral Flow Electrochemical Device. Anal

Biosensors/molecular 15 tools for detection of waterborne pathogens

A sensitive label-free impedimetric DNA biosensor based on silsesquioxane-19 functionalized gold nanoparticles for Zika Virus detection

CRISPR-cas biology and its application to infectious

Nanotechnology-Enabled Approaches against the COVID-19 Pandemic

The origins and the future of microfluidics

Development of a Laboratory-safe and Low-cost Detection Protocol for

COVID-19)

Evaluation of enzyme-12 linked immunoassay and colloidal gold-immunochromatographic assay kit for detection 13 of novel coronavirus (SARS-Cov-2) causing an outbreak of pneumonia

Trends and Perspectives of 19

Rapid detection for primary screening of influenza A virus: 23 microfluidic RT-PCR chip and electrochemical DNA sensor

Magnetic molecularly imprinted electrochemical sensors: A review

Biosensors for hepatitis B virus detection

Nanostructures in Biosensor-A Review

Disposable and portable electrochemical aptasensor for label free detection of

aflatoxin B1 in alcoholic beverages

Label-Free DNA Biosensor for Electrochemical 4 Detection of Short DNA Sequences Related to Human Papilloma Virus

A portable paper-based microfluidic platform for multiplexed 7 electrochemical detection of human immunodeficiency virus and hepatitis C virus 8 antibodies in serum

Ultrasensitive supersandwich-type 11 electrochemical sensor for SARS-CoV-2 from the infected COVID-19 patients using a 12 smartphone

A simple magnetic 15 nanoparticles-based viral RNA extraction method for efficient detection of SARS-CoV-2

Electrochemical 18

Magnetoimmunosensing Approach for the Sensitive Detection of H9N2 Avian Influenza 19 Virus Particles

Aptamer-based biosensors for

AuE -gold electrode; MWCNT -multi-wall carbon nanotubes; PPNWs -polypyrrole nanowires

GNPs -gold nanoparticles; DPV -differential pulse voltammetry; ASVanodic stripping voltammetry; SWV -square wave voltammetry; EIS -electrochemical impedance spectroscopy

MµBs -magnetic microbeads; PFU -Plaque forming units

CPPyNW -carboxylic polypyrrole nanowires; GCE -glassy carbon electrode

GQD -graphene quantum dots; FET -field effect transistor

APTES -triethoxysilane on silicon substrates

Au NPs -Gold nanoparticles; PANI-MWCNT -polyanilinemultiwalled carbon nanotube; GC -Glassy carbon; rGO -reduced graphene oxide; MoS 2 -molybdenum sulfide; acpcPNA -anthraquinone-labeled 28 pyrrolidinyl peptide nucleic acid

PGE -pencil graphite electrode; PET -polyethylene terephthalate

Potential conflict of interest exists:We wish to draw the attention of the Editor to the following facts, which may be considered as potential conflicts of interest, and to significant financial contributions to this work:The nature of potential conflict of interest is described below:No conflict of interest exists.We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.

Funding was received for this work.All of the sources of funding for the work described in this publication are acknowledged below:

No funding was received for this work.

We confirm that we have given due consideration to the protection of intellectual property associated with this work and that there are no impediments to publication, including the timing of publication, with respect to intellectual property. In so doing we confirm that we have followed the regulations of our institutions concerning intellectual property.

We further confirm that any aspect of the work covered in this manuscript that has involved human patients has been conducted with the ethical approval of all relevant bodies and that such approvals are acknowledged within the manuscript.IRB approval was obtained (required for studies and series of 3 or more cases) Written consent to publish potentially identifying information, such as details or the case and photographs, was obtained from the patient(s) or their legal guardian(s).

The International Committee of Medical Journal Editors (ICMJE) recommends that authorship be based on the following four criteria:1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND 2. Drafting the work or revising it critically for important intellectual content; AND 3. Final approval of the version to be published; AND 4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.All those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. For more information on authorship, please see http://www.icmje.org/recommendations/browse/roles-andresponsibilities/defining-the-role-of-authors-and-contributors.html#two.J o u r n a l P r e -p r o o f 3 All listed authors meet the ICMJE criteria. We attest that all authors contributed significantly to the creation of this manuscript, each having fulfilled criteria as established by the ICMJE.One or more listed authors do(es) not meet the ICMJE criteria.We believe these individuals should be listed as authors because:

We confirm that the manuscript has been read and approved by all named authors.We confirm that the order of authors listed in the manuscript has been approved by all named authors.

The Corresponding Author declared on the title page of the manuscript is:

This author submitted this manuscript using his/her account in EVISE.We understand that this Corresponding Author is the sole contact for the Editorial process (including EVISE and direct communications with the office). He/she is responsible for communicating with the other authors about progress, submissions of revisions and final approval of proofs.We confirm that the email address shown below is accessible by the Corresponding Author, is the address to which Corresponding Author's EVISE account is linked, and has been configured to accept email from the editorial office of American Journal of Ophthalmology Case Reports: 

We understand that this author is the sole contact for the Editorial process (including EVISE and direct communications with the office). He/she is responsible for communicating with the other authors, including the Corresponding Author, about progress, submissions of revisions and final approval of proofs.We the undersigned agree with all of the above.

Author's name (Fist, Last) Signature Date 1. Yugender Goud Kotagiri January 5 th 2021